BACKGROUND
The efficacy and safety of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis is still a matter of debate.
METHODS
Using a… (More)
BACKGROUND
The efficacy and safety of thromboprophylaxis in patients with acute medical illnesses who may be at risk for venous thromboembolism have not been determined in adequately designed trials.… (More)
BACKGROUND
The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis… (More)
BACKGROUND
The efficacy and safety of anticoagulant treatment for patients with acute, symptomatic superficial-vein thrombosis in the legs, but without concomitant deep-vein thrombosis or symptomatic… (More)
Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Results of trials in non-end-stage renal disease (ESRD) patients cannot be extrapolated to patients with… (More)
BACKGROUND
There is limited information about risk factors for venous thromboembolism (VTE) in acutely ill hospitalized general medical patients.
METHODS
An international, randomized,… (More)
BACKGROUND
Superficial venous thrombosis (SVT) is perceived to have a benign prognosis.
OBJECTIVE
To assess the prevalence of venous thromboembolism in patients with SVT and to determine the… (More)
IMPORTANCE
Although retrievable inferior vena cava filters are frequently used in addition to anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is unclear.
… (More)
BACKGROUND
Considerable variability exists in the use of pharmacological thromboprophylaxis among acutely ill medical patients, partly because clinically relevant end points have not been fully… (More)
BACKGROUND
CAPTIM was a randomized trial comparing prehospital thrombolysis with transfer to an interventional facility (and, if needed, percutaneous intervention) with primary percutaneous coronary… (More)